Washington, D.C.— Today the Senate voted to confirm Robert Califf as the next commissioner of the Food and Drug Administration (FDA).
A statement from Karen E. Knudsen, CEO of American Cancer Society American Cancer Society Cancer Action Network (ACS CAN) and Lisa Lacasse, president of ACS CAN follows:
“From reviewing and approving innovative therapies, to being given the mandate to regulate the entire tobacco industry, the work of the FDA plays a critical role in the fight against cancer. Given the complex and far-reaching work of the agency on cancer patients and families, a confirmed commissioner is vital to the agency’s work. We look forward to working with Dr. Califf at FDA to:
“On behalf of families affected by cancer, ACS CAN urges Dr. Califf and FDA to press forward on these critical issues that have impact on a disease that is expected to kill more than 609,000 Americans this year alone. Advancing cancer science into implementation is critical to improving the lives of cancer patients and their families.”
###